These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27216051)

  • 1. Imidazo[1,2-a]Pyridine-3-Carboxamides Are Active Antimicrobial Agents against Mycobacterium avium Infection In Vivo.
    Moraski GC; Cheng Y; Cho S; Cramer JW; Godfrey A; Masquelin T; Franzblau SG; Miller MJ; Schorey J
    Antimicrob Agents Chemother; 2016 Aug; 60(8):5018-22. PubMed ID: 27216051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
    J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations.
    Andréjak C; Almeida DV; Tyagi S; Converse PJ; Ammerman NC; Grosset JH
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2129-35. PubMed ID: 25624335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility and molecular characterization of Mycobacterium intracellulare in China.
    Zhao X; Wang Y; Pang Y
    Infect Genet Evol; 2014 Oct; 27():332-8. PubMed ID: 25131955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antimicrobial activity of new quinolones against Mycobacterium avium and Mycobacterium intracellulare determined by the dilution methods using 7H11 agar and Ogawa egg media].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 May; 68(5):367-70. PubMed ID: 8331881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the activity of fluoroquinolones against Mycobacterium avium in cell-free systems and a human monocyte in-vitro infection model.
    Shiratsuchi H; Jacobs MR; Pearson AJ; Venkataprasad N; Klopman G; Ellner JJ
    J Antimicrob Chemother; 1996 Mar; 37(3):491-500. PubMed ID: 9182106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of activities of amikacin and sulphamethoxazole against Mycobacterium avium-intracellulare.
    Yew WW; Tam CM; Chan CY; Li MS; Cheng AF
    Int J Clin Pharmacol Res; 1993; 13(2):65-8. PubMed ID: 8354590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of 12 antimicrobial peptides against Mycobacterium tuberculosis and Mycobacterium avium clinical isolates.
    Portell-Buj E; Vergara A; Alejo I; López-Gavín A; Monté MR; San Nicolás L; González-Martín J; Tudó G
    J Med Microbiol; 2019 Feb; 68(2):211-215. PubMed ID: 30570475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1996 Sep; 71(9):531-5. PubMed ID: 8999135
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular Mycobacterium avium.
    Deshpande D; Srivastava S; Meek C; Leff R; Gumbo T
    Antimicrob Agents Chemother; 2010 May; 54(5):1728-33. PubMed ID: 20231389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility testing and genotyping of Mycobacterium avium isolates of two tertiary tuberculosis designated hospital, China.
    Wei G; Huang M; Wang G; Huo F; Dong L; Li Y; Huang H
    Infect Genet Evol; 2015 Dec; 36():141-146. PubMed ID: 26391006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting emerging
    Mattoo R
    Future Microbiol; 2021 Jul; 16():753-764. PubMed ID: 34227394
    [No Abstract]   [Full Text] [Related]  

  • 15. [Azithromycin and Mycobacterium avium infection].
    Perronne C
    Pathol Biol (Paris); 1995 Jun; 43(6):565-7. PubMed ID: 8539084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetyl-cysteine mediates protection against Mycobacterium avium through induction of human β-defensin-2 in a mouse lung infection model.
    Shiozawa A; Kajiwara C; Ishii Y; Tateda K
    Microbes Infect; 2020; 22(10):567-575. PubMed ID: 32882411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M avium complex lung disease.
    Koh WJ; Jeong BH; Jeon K; Lee NY; Lee KS; Woo SY; Shin SJ; Kwon OJ
    Chest; 2012 Dec; 142(6):1482-1488. PubMed ID: 22628488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan.
    Kohno Y; Ohno H; Miyazaki Y; Higashiyama Y; Yanagihara K; Hirakata Y; Fukushima K; Kohno S
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4071-6. PubMed ID: 17709469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type frequency and antimicrobial susceptibility of Mycobacterium avium-intracellulare complex strains isolated in Italy from AIDS and non-AIDS patients.
    Fattorini L; Vincent V; Li B; Xiao Y; Varnerot A; Tortoli E; Piersimoni C; Mandler F; Mascellino MT; Iona E; Orefici G
    J Chemother; 1996 Feb; 8(1):37-42. PubMed ID: 8835106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.